Preview
Sign-in for full Details 
Sign-in free and Explore the Exciting World of BiomedExperts:
- Over 1.500.000 Profiles
- More than 1.800 Organizations worldwide
- State of the Art Network Visualizations
- Manage your own Profile
- Locate Experts in your Country/Region
- Locate Experts in your 1. and 2. Level Network
- Connect to Experts Worldwide
NetworkView
A Hadengue
This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers
together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles
free of charge to researchers worldwide.
Research Profile (preview)
Physiology
Disorders
Living Beings
Phenomena
Chemicals & Drugs
Anatomy
Sign-in to see full Profile
Network (preview)
51
Lebrec, Didier
41
Moreau, Richard
17
Sogni, Philippe
13
Soupison, T
7
Gadano, AC
6
Yang, S
5
Cailmail, S
5
Durand, François
5
Vachiery, F
4
Valla, Dominique
3
Ozier, Yves
3
Kirstetter, P
3
Erlinger, S
2
Bernuau, Jacques
2
Le Moine, Olivier
Sign-in to see all Coauthors
Publications
Sign-in to see all Publications
Sign in free and see...
Visualized networks:
See your personal network in
sophisticated graphical views
GeoTargeted Searches:
Locate experts around the world
and connect with global collaborators
Research Profiles:
See the visualized research activity
of experts around the globe
Sign-in to see more
Geonetwork of A Hadengue (preview)
Cities where this author has publications
Cities where co-authors of this author have publications
Sign-in to see more
All Publications
-
1998: Hadengue A; Gadano A; Moreau R; Giostra E; Durand F; Valla D; Erlinger S; Lebrec D
Beneficial effects of the 2-day administration of terlipressin in patients with cirrhosis and hepatorenal syndrome.
Journal of hepatology 1998;29(4):565-70.
-
1997: Gadano A; Durand F; Degott C; Dosquet C; Moreau R; Hadengue A; Widmann J J; Vachiery F; Elman A; Sogni P; Yang S; Valla D; Bernuau J; Belghiti J; Erlinger S; Lebrec D
Studies of portal hemodynamics and hepatic oxygen consumption during acute liver allograft rejection.
Transplantation 1997;64(8):1188-92.
-
1997: Vachiéry F; Moreau R; Hadengue A; Gadano A; Soupison T; Valla D; Lebrec D
Hypoxemia in patients with cirrhosis: relationship with liver failure and hemodynamic alterations.
Journal of hepatology 1997;27(3):492-5.
-
1997: Le Moine O; Hadengue A; Moreau R; Sogni P; Soupison T; Yang S; Hartleb M; Lebrec D
Relationship between portal pressure, esophageal varices, and variceal bleeding on the basis of the stage and cause of cirrhosis.
Scandinavian journal of gastroenterology 1997;32(7):731-5.
-
1997: Gadano A; Moreau R; Vachiery F; Soupison T; Yang S; Cailmail S; Sogni P; Hadengue A; Durand F; Valla D; Lebrec D
Natriuretic response to the combination of atrial natriuretic peptide and terlipressin in patients with cirrhosis and refractory ascites.
Journal of hepatology 1997;26(6):1229-34.
-
1997: Sogni P; Hadengue A; Moreau R; Le Moine O; Soupison T; Oberti F; Farinotti R; Lebrec D
Acute effects of propylthiouracil on hemodynamics and oxygen content in patients with alcoholic cirrhosis.
Journal of hepatology 1997;26(3):628-33.
-
1997: Gadano A; Hadengue A; Vachiery F; Moreau R; Sogni P; Soupison T; Yang S; Cailmail S; Lebrec D
Relationship between hepatic blood flow, liver tests, haemodynamic values and clinical characteristics in patients with chronic liver disease.
Journal of gastroenterology and hepatology 1997;12(2):167-71.
-
1996: Vachiery F; Moreau R; Gadano A; Yang S; Sogni P; Hadengue A; Cailmail S; Soupison T; Lebrec D
Hemodynamic and metabolic effects of terlipressin in patients with cirrhosis receiving a nonselective beta-blocker.
Digestive diseases and sciences 1996;41(9):1722-6.
-
1995: Le Moine O; Soupison T; Sogni P; Marchant A; Moreau R; Hadengue A; Goldman M; Devière J; Lebrec D
Plasma endotoxin and tumor necrosis factor-alpha in the hyperkinetic state of cirrhosis.
Journal of hepatology 1995;23(4):391-5.
-
1995: Gadano A; Hadengue A; Widmann J J; Vachiery F; Moreau R; Yang S; Soupison T; Sogni P; Degott C; Durand F
Hemodynamics after orthotopic liver transplantation: study of associated factors and long-term effects.
Hepatology (Baltimore, Md.) 1995;22(2):458-65.
-
1994: Sogni P; Soupison T; Moreau R; Le Moine O; Bacq Y; Hadengue A; Lebrec D
Hemodynamic effects of acute administration of furosemide in patients with cirrhosis receiving beta-adrenergic antagonists.
Journal of hepatology 1994;20(4):548-52.
-
1994: Hartleb M; Kirstetter P; Moreau R; Soupison T; Pussard E; Hadengue A; Sogni P; Gaudin C; Lebrec D
[Relationships between plasma concentrations of endothelin and the severity of liver cirrhosis]
Gastroentérologie clinique et biologique 1994;18(5):407-12.
-
1993: Moreau R; Hadengue A; Soupison T; Mamzer M F; Kirstetter P; Saraux J L; Assous M; Roche-Sicot J; Sicot C
Arterial and mixed venous acid-base status in patients with cirrhosis. Influence of liver failure.
Liver 1993;13(1):20-4.
-
1993: Hadengue A; Lebrec D; Moreau R; Sogni P; Durand F; Gaudin C; Bernuau J; Belghiti J; Gayet B; Erlinger S
Persistence of systemic and splanchnic hyperkinetic circulation in liver transplant patients.
Hepatology (Baltimore, Md.) 1993;17(2):175-8.
-
1993: Lebrec D; Moreau R; Cailmail S; Sogni P; Oberti F; Hadengue A
Effects of terlipressin on hemodynamics and oxygen content in conscious portal vein stenosed and cirrhotic rats receiving propranolol.
Journal of hepatology 1993;17(1):102-7.
-
1993: Moreau R; Gaudin C; Hadengue A; Braillon A; Roulot D; Bacq Y; Lebrec D
Renal hemodynamics in patients with cirrhosis: relationship with ascites and liver failure.
Nephron 1993;65(3):359-63.
-
1992: Sogni P; Moreau R; Ohsuga M; Cailmail S; Oberti F; Hadengue A; Pussard E; Lebrec D
Evidence for normal nitric oxide-mediated vasodilator tone in conscious rats with cirrhosis.
Hepatology (Baltimore, Md.) 1992;16(4):980-3.
-
1992: Koshy A; Sekiyama T; Hadengue A; Cerini R; Braillon A; Lebrec D
Effects of alpha 1 and beta-adrenergic antagonists and 5-hydroxytryptamine receptor antagonist on portal-systemic collateral vascular resistance in conscious rats with portal hypertension.
Journal of gastroenterology and hepatology 1992;7(5):449-54.
-
1992: Moreau R; Soubrane O; Sogni P; Hadengue A; Gaudin C; Lin H C; Pussard E; Nahoul K; Lebrec D
Hemodynamic, neurohumoral, and metabolic responses to amino acid infusion in patients with cirrhosis.
Gastroenterology 1992;103(2):601-8.
-
1992: Moreau R; Hadengue A; Soupison T; Kirstetter P; Mamzer M F; Vanjak D; Vauquelin P; Assous M; Sicot C
Septic shock in patients with cirrhosis: hemodynamic and metabolic characteristics and intensive care unit outcome.
Critical care medicine 1992;20(6):746-50.
-
1992: Hadengue A; Moreau R; Gaudin C; Bacq Y; Champigneulle B; Lebrec D
Total effective vascular compliance in patients with cirrhosis: a study of the response to acute blood volume expansion.
Hepatology (Baltimore, Md.) 1992;15(5):809-15.
-
1992: Roulot D; Moreau R; Gaudin C; Bacq Y; Braillon A; Hadengue A; Frohly P; Lebrec D
Long-term sympathetic and hemodynamic responses to clonidine in patients with cirrhosis and ascites.
Gastroenterology 1992;102(4 Pt 1):1309-18.
-
1992: Brenard R; Moreau R; Pussard E; Champigneulle B; Gaudin C; Hadengue A; Braillon A; Lebrec D
Hemodynamic and sympathetic responses to human atrial natriuretic peptide infusion in patients with cirrhosis.
Journal of hepatology 1992;14(2-3):347-56.
-
1992: Poo J L; Braillon A; Hadengue A; Gaudin C; Lebrec D
Hemodynamic effects of terbutaline, a beta 2-adrenoceptor agonist, in conscious rats with secondary biliary cirrhosis.
Hepatology (Baltimore, Md.) 1992;15(3):459-63.
-
1992: Gaudin C; Braillon A; Moreau R; Roulot D; Hadengue A; Lebrec D
[Renal sympathetic nervous activity in patients with cirrhosis]
Gastroentérologie clinique et biologique 1992;16(6-7):498-503.
-
1992: Moreau R; Soubrane O; Hadengue A; Sogni P; Gaudin C; Kleber G; Lebrec D
[Hemodynamic effects of the administration of terlipressin alone or combined with nitroglycerin in patients with cirrhosis]
Gastroentérologie clinique et biologique 1992;16(8-9):680-6.
-
1992: Moreau R; Hadengue A; Gaudin C; Sogni P; Soubrane O; Lebrec D
[Effect of the severity of liver disease on renal hemodynamics and renal oxygen consumption in patients with cirrhosis]
Gastroentérologie clinique et biologique 1992;16(4):309-13.
-
1991: Moreau R; Hadengue A; Pussard E; Soubrane O; Sogni P; Gaudin C; Lebrec D
Relationships between plasma atrial natriuretic peptide concentrations and hemodynamics and hematocrit in patients with cirrhosis.
Hepatology (Baltimore, Md.) 1991;14(6):1035-9.
-
1991: Bacq Y; Gaudin C; Hadengue A; Roulot D; Braillon A; Moreau R; Lebrec D
Systemic, splanchnic and renal hemodynamic effects of a dopaminergic dose of dopamine in patients with cirrhosis.
Hepatology (Baltimore, Md.) 1991;14(3):483-7.
-
1991: Gaudin C; Braillon A; Poo J L; Moreau R; Hadengue A; Lebrec D
Regional sympathetic activity, severity of liver disease and hemodynamics in patients with cirrhosis.
Journal of hepatology 1991;13(2):161-8.
-
1991: Lee S S; Hadengue A; Girod C; Braillon A; Lebrec D
Divergent circulatory effects of betaxolol in conscious and anesthetized normal and portal hypertensive rats.
Journal of hepatology 1991;12(2):157-61.
-
1991: Hadengue A; Moreau R; Bacq Y; Gaudin C; Braillon A; Lebrec D
Selective dopamine DA1 stimulation with fenoldopam in cirrhotic patients with ascites: a systemic, splanchnic and renal hemodynamic study.
Hepatology (Baltimore, Md.) 1991;13(1):111-6.
-
1990: Lebrec D; Hadengue A; Gaudin C; Levron J C; Fraitag B; Berthelot P; Benhamou J P
Pharmacokinetics of ketanserin in patients with cirrhosis.
Clinical pharmacokinetics 1990;19(2):160-6.
-
1990: Moreau R; Hadengue A; Soupison T; Mechin G; Assous M; Roche-Sicot J; Sicot C
Abnormal pressor response to vasopressin in patients with cirrhosis: evidence for impaired buffering mechanisms.
Hepatology (Baltimore, Md.) 1990;12(1):7-12.
-
1990: Koshy A; Sekiyama T; Cereda J M; Hadengue A; Girod C; Lebrec D
Effects of haemorrhage and volume expansion on portal-systemic collateral vascular resistance in conscious portal hypertensive rats.
Clinical science (London, England : 1979) 1990;78(2):193-7.
-
1990: Hadengue A
[Vasoactive treatment in digestive hemorrhage caused by rupture of esophageal varices]
Gastroentérologie clinique et biologique 1990;14(1 ( Pt 2)):52B-57B.
-
1989: Moreau R; Braillon A; Roulot D; Hadengue A; Gaudin C; Cereda J M; Sicot C; Lebrec D
[Tissue hypoxia and hepatocellular insufficiency in patients with cirrhosis]
Gastroentérologie clinique et biologique 1989;13(12):978-83.
-
1989: Ozier Y; Braillon A; Gaudin C; Roulot D; Hadengue A; Lebrec D
Hepatic denervation alters hemodynamic response to hemorrhage in conscious rats.
Hepatology (Baltimore, Md.) 1989;10(4):473-6.
-
1989: Koshy A; Moreau R; Cerini R; Roulot D; Bacq Y; Hadengue A; Lebrec D
Effects of oxygen inhalation on tissue oxygenation in patients with cirrhosis. Evidence for an impaired arterial baroreflex control.
Journal of hepatology 1989;9(2):240-5.
-
1989: Gaudin C; Braillon A; Moreau R; Roulot D; Bacq Y; Hadengue A; Lebrec D
[Relation between plasma catecholamines, the severity of the liver disease and hemodynamics in patients with cirrhosis]
Gastroentérologie clinique et biologique 1989;13(8-9):701-6.
-
1989: Cerini R; Braillon A; Hadengue A; Koshy A; Lee S S; Lebrec D
Somatostatin analogue improves survival in conscious cirrhotic rats subjected to gastrointestinal bleeding.
Clinical science (London, England : 1979) 1989;77(1):7-9.
-
1989: Cerini R; Koshy A; Hadengue A; Lee S S; Garnier P; Lebrec D
Effects of glucagon on systemic and splanchnic circulation in conscious rats with biliary cirrhosis.
Journal of hepatology 1989;9(1):69-74.
-
1989: Moreau R; Roulot D; Braillon A; Gaudin C; Hadengue A; Bacq Y; Lebrec D
Low dose of nitroglycerin failed to improve splanchnic hemodynamics in patients with cirrhosis: evidence for an impaired cardiopulmonary baroreflex function.
Hepatology (Baltimore, Md.) 1989;10(1):93-7.
-
1989: Moreau R; Lee S S; Hadengue A; Ozier Y; Sicot C; Lebrec D
Relationship between oxygen transport and oxygen uptake in patients with cirrhosis: effects of vasoactive drugs.
Hepatology (Baltimore, Md.) 1989;9(3):427-32.
-
1989: Koshy A; Girod C; Lee S S; Hadengue A; Cerini R; Lebrec D
Discrepancy between portal pressure and systemic hemodynamic changes after incremental doses of propranolol in awake portal hypertensive rats.
Hepatology (Baltimore, Md.) 1989;9(2):269-73.
-
1989: Hadengue A; Moreau R; Cerini R; Koshy A; Lee S S; Lebrec D
Combination of ketanserin and verapamil or propranolol in patients with alcoholic cirrhosis: search for an additive effect.
Hepatology (Baltimore, Md.) 1989;9(1):83-7.
-
1989: Ozier Y; Braillon A; Gaudin C; Roulot D; Hadengue A; Lebrec D
[Liver denervation aggravates the hemodynamic response to hemorrhage in the conscious rat]
Annales françaises d'anesthèsie et de rèanimation 1989;8 Suppl():R111.
-
1988: Koshy A; Cerini R; Bernuau D; Hadengue A; Girod C; Lebrec D
Model for the study of portal-systemic collateral vascular resistance in the conscious rat.
Journal of pharmacological methods 1988;20(3):265-77.
-
1988: Lee S S; Moreau R; Hadengue A; Cerini R; Koshy A; Lebrec D
Glucagon selectively increases splanchnic blood flow in patients with well-compensated cirrhosis.
Hepatology (Baltimore, Md.) 1988;8(6):1501-5.
-
1988: Lee S S; Hadengue A; Moreau R; Sayegh R; Hillon P; Lebrec D
Postprandial hemodynamic responses in patients with cirrhosis.
Hepatology (Baltimore, Md.) 1988;8(3):647-51.
-
1988: Hadengue A; Lee S S; Koshy A; Girod C; Lebrec D
Regional blood flows by the microsphere method: reproducibility in portal hypertensive rats and influence of a portal vein catheter.
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.) 1988;187(4):461-8.
-
1988: Hadengue A; Moreau R; Lee S S; Gaudin C; Rueff B; Lebrec D
Liver hypermetabolism during alcohol withdrawal in humans. Role of sympathetic overactivity.
Gastroenterology 1988;94(4):1047-52.
-
1988: Jiron M I; Lee S S; Cerini R; Pugliese D; Hadengue A; Lebrec D
Effects of nitroglycerin on forearm haemodynamics in patients with cirrhosis.
Clinical science (London, England : 1979) 1988;74(4):433-6.
-
1988: Cerini R; Lee S S; Hadengue A; Koshy A; Girod C; Lebrec D
Circulatory effects of somatostatin analogue in two conscious rat models of portal hypertension.
Gastroenterology 1988;94(3):703-8.
-
1987: Lee S S; Hadengue A; Moreau R; Girod C; Jiron M I; Lebrec D
Naloxone does not alter haemodynamics in cirrhosis. Studies in humans and rats.
Journal of hepatology 1987;5(2):149-53.
-
1987: Hadengue A; Lee S S; Moreau R; Lebrec D
Oxygen and bile acid content in the azygos blood. Clues to the azygos derivation in patients with portal hypertension.
Journal of hepatology 1987;5(1):98-101.
Sign-in to see more
